Latest News

Date Title Topic
24 Feb 2014 Bevacizumab Fails to Improve Overall Survival in First-Line Treatment for Glioblastoma Central nervous system malignancies - Anticancer agents & Biologic therapy
24 Feb 2014 2nd ESMO Consensus Conference on Lung Cancer – NSCLC
17 Feb 2014 R-GCVP as First Line Treatment for DLBCL Patients with Cardiac Comorbidity Haematologic malignancies
17 Feb 2014 How to Reset Strategies to Maximise the Potential of PI3K/AKT/mTOR Inhibitors in Cancer Therapy Anticancer agents & Biologic therapy
14 Feb 2014 ESMO Interview: Franco Cavalli Comments on the Release of the World Cancer Report 2014 Bioethics, legal and economic issues
13 Feb 2014 FDA Approves Ibrutinib for Chronic Lymphocytic Leukaemia Haematologic malignancies - Anticancer agents & Biologic therapy
12 Feb 2014 Who are the Originators of Innovative Medicines in the EU? Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
11 Feb 2014 Rare Cancers: The Challenge of Accurate Diagnosis
06 Feb 2014 World Cancer Report 2014 Epidemiology/Etiology/Cancer Prevention
06 Feb 2014 ECC 2013 Webcasts
05 Feb 2014 SWITCH Study of Efficacy and Safety of Sorafenib/Sunitinib vs. Sunitinib/Sorafenib in the Treatment of mRCC Genitourinary cancers - Anticancer agents & Biologic therapy
04 Feb 2014 Enzalutamide in Chemotherapy-Naive mCRPC Genitourinary cancers - Anticancer agents & Biologic therapy
04 Feb 2014 ESMO Supports World Cancer Day 2014 Bioethics, legal and economic issues